Opendata, web and dolomites

BCLLatlas SIGNED

Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BCLLatlas project word cloud

Explore the words cloud of the BCLLatlas project. It provides you a very rough idea of what is the project "BCLLatlas" about.

computational    evolution    origin    pools    epigenomics    lymphocytic    atlas    cell    stages    course    deciphering    clinical    world    monoclonal    dynamics    samples    transformation    clonal    frequent    initial    last    expertise    diagnosis    maps    revealed    maturation    medicine    technologies    modulated    insights    teams    generating    minute    transcriptomics    proliferations    implications    precision    decipher    leukemia    groups    leukemic    entire    time    fulfill    locations    generate    disease    treatment    architecture    transcriptional    pathology    thousands    bcll    analytical    cancer    western    subpopulations    unprecedented    las    normal    points    deep    single    scenario    hundred    healthy    richness    complementary    subclonality    cells    clinics    subtypes    understand    genomics    neoplastic    cellular    dynamically    genetic    aggressiveness    subclonal    era    revolutionizing    chronic    life    anatomy    profiling    diversity    unbiased    differentiation    biology    plan    sequencing    goals    epigenetic    cll    history    individuals    molecular   

Project "BCLLatlas" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO CENTRE DE REGULACIO GENOMICA 

Organization address
address: CARRER DOCTOR AIGUADER 88
city: BARCELONA
postcode: 8003
website: www.crg.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 8˙333˙331 €
 EC max contribution 8˙333˙331 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-SyG
 Funding Scheme ERC-SyG
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2024-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO CENTRE DE REGULACIO GENOMICA ES (BARCELONA) coordinator 5˙451˙231.00
2    CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER ES (BARCELONA) participant 2˙882˙100.00

Map

 Project objective

Unbiased analyses of the molecular make up of single cells are revolutionizing our understanding of cell differentiation and cancer. Over the last years, our groups have characterized the molecular features of normal B-cell subpopulations and of pools of leukemic cells from chronic lymphocytic leukemia (CLL), the most frequent leukemia in the Western world. These analyses have revealed that CLL subtypes are related to different B-cell maturation stages, and that they can show a complex subclonal architecture. Such subclonality is dynamically modulated during the course of the disease, and has deep implications in CLL biology, clinical aggressiveness and treatment responses. In this scenario, BCLL@las aims at deciphering the origin and molecular anatomy of CLL during the entire life history of the disease by generating genetic, transcriptional and epigenetic maps of hundred-thousands of single cells across locations, time points and individuals. We plan to fulfill four major objectives: 1) To generate a comprehensive atlas of normal B-cell maturation, 2) To understand the initial steps of neoplastic transformation through the analysis of minute B-cell monoclonal proliferations in healthy individuals, 3) To decipher the cellular diversity and clonal architecture of CLL at diagnosis, and 4) To characterize the single-cell subclonal dynamics of CLL during disease evolution and treatment response. To reach these goals, BCLL@las gathers together four teams with complementary expertise in B-cell biology, clinics and pathology of CLL, genomics, transcriptomics, epigenomics, sequencing technologies, single-cell profiling and computational biology. This, together with the richness of the available CLL samples and the technical and analytical depth of BCLL@las shall lead to unprecedented insights into the origin and evolution of cancer in the precision medicine era.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BCLLATLAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BCLLATLAS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More